Wave Life Sciences Shares Surge 121% on Obesity Drug WVE-007 Trial Results; GeeFi Presale Hits $1.4M as Visa Integration Fuels 667% ROI Hopes
TL;DR
* Terns Pharmaceuticals raises $747.5M in equity offering after TERN-701 shows 64% improvement in chronic myeloid leukemia patients over 24 weeks
* Wave Life Sciences shares surge 121% as WVE-007 obesity trial delivers 9.4% visceral fat reduction and 3.2% lean mass gain in Phase 1
* ServiceNow in